TrialInternational journal of radiation oncology, biology, physics2026

Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.

Jonathan So et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.